Skip to main content

Loading market data...

MDT

Medtronic plc

NYSE • United states

$93.03

-$1.60

(-1.69%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Medtronic plc (MDT)

Unavailable

Quotes may be delayed

$119.00B

Market Cap

10,449,505

Volume

Unavailable

P/E Ratio

3.01%

Div Yield

Medtronic plc Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

19 Oct 2026

Medtronic plc reported A director or senior management change or compensation event

Medtronic plc filed an 8-K covering a director or senior management change or compensation event, shareholder voting results, Regulation FD disclosure, supporting financial statements or exhibits.

17 Oct 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Medtronic plc.

14 Oct 2026

Medtronic plc business combination filing

Medtronic plc filed Form 425 (communications about a business combination).

13 Oct 2026

Medtronic plc business combination filing

Medtronic plc filed Form 425 (communications about a business combination).

10 Oct 2026

Medtronic plc business combination filing

Medtronic plc filed Form 425 (communications about a business combination).

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$1.69B

Total assets (USD)$93.31B

Total liabilities (USD)$42.46B

Shareholders' equity (USD)$50.23B

Long-term debt (USD)$22.14B

Debt due within a year (USD)$2.54B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 31 Jul 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$9.76B	$1.76B	$1.47B	$1.14	10-Q · 3 Sep 2026
Q4 2025	$9.02B	$1.46B	$1.14B	$0.89	10-Q · 24 Feb 2026
Q3 2025	$8.96B	$1.69B	$1.37B	$1.07	10-Q · 25 Nov 2025
Q2 2025	$8.58B	$1.45B	$1.04B	$0.81	10-Q · 3 Sep 2026
Q1 2025	$8.29B	$1.65B	$1.29B	$1.01	10-Q · 25 Feb 2025
Q4 2024	$8.29B	$1.65B	$1.29B	$1.01	10-Q · 24 Feb 2026

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $103.19

10.9% upside potential

📈

Strong Buy

Unavailable

👍

Buy

10

⏸️

Hold

9

📉

Sell

0

19 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 20:49 UTC Targets range 85.00–118.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

15

Oct 2026

Marinaro Michael

EVP, Pres MedSurg and Americas

Open-market sale

$96.00 per share

10,420 shares

15

Oct 2026

Martha Geoffrey

Director, Chairman and CEO

Open-market sale

$95.00 per share

50,000 shares

15

Oct 2026

Medtronic plc

10% owner

Other

Unavailable per share

252,813,348 shares

16

Sep 2026

KIIL HARRY SKIP

EVP & President Cardiovascular

Open-market sale

$93.65 per share

1,483 shares

15

Sep 2026

Blomquist Denise L.

Chief Accounting Officer

Gift

Unavailable per share

600 shares

20

Aug 2026

Marinaro Michael

EVP, Pres MedSurg and Americas

Tax withholding

$92.30 per share

1,084 shares

3

Aug 2026

Blomquist Denise L.

Chief Accounting Officer

Grant or award

Unavailable per share

2,337 shares

3

Aug 2026

Walter Matthew R.

SVP, Chief HR Officer

Grant or award

Unavailable per share

5,769 shares

31

Jul 2026

Blomquist Denise L.

Chief Accounting Officer

Tax withholding

$85.39 per share

212 shares

31

Jul 2026

Walter Matthew R.

SVP, Chief HR Officer

Tax withholding

$85.39 per share

1,675 shares

Top Shareholders

Vanguard Group Inc

128,961,343 shares

1.486% change

12/31/2025

Blackrock, Inc.

114,020,787 shares

0.741% change

6/30/2026

Vanguard Capital Management Llc

83,816,735 shares

0.579% change

6/30/2026

State Street Corp

63,399,315 shares

2.686% change

6/30/2026

Vanguard Portfolio Management Llc

34,059,967 shares

1.822% change

6/30/2026

Geode Capital Management, Llc

30,192,015 shares

5.066% change

6/30/2026

Jpmorgan Chase & Co

27,784,471 shares

-45.492% change

6/30/2026

Bank Of America Corp /De/

21,322,401 shares

-18.038% change

6/30/2026

Massachusetts Financial Services Co /Ma/

19,872,600 shares

-7.3% change

6/30/2026

Morgan Stanley

19,444,871 shares

-6.141% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 20:49 UTC· 10 hours ago

Research coverage and investment tools

Medtronic plc (MDT) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus). Its last price was US$93.03 on 21 Oct 2026. That is 60% of the way from its 52-week low of US$73.31 to its 52-week high of US$106.33. It paid US$2.86 a share in dividends over the last 12 months, a dividend yield of 3.01%. The latest ex-dividend date on file is 25 Sep 2026. Its market capitalisation was US$119 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$9.76B	$1.76B	$1.47B	$1.14	—	18.1%	$1.29B	10-Q · 3 Sep 2026 (opens in a new tab)
Q4 2025	$9.02B	$1.46B	$1.14B	$0.89	—	16.2%	—	10-Q · 24 Feb 2026 (opens in a new tab)
Q3 2025	$8.96B R (restated)	$1.69B R (restated)	$1.37B R (restated)	$1.07 R (restated)	—	18.8%	$584.00M	10-Q · 25 Nov 2025 (opens in a new tab)
Q2 2025	$8.58B	$1.45B	$1.04B	$0.81	—	16.8%	$584.00M	10-Q · 3 Sep 2026 (opens in a new tab)
Q1 2025	$8.29B	$1.65B	$1.29B	$1.01	—	19.9%	—	10-Q · 25 Feb 2025 (opens in a new tab)
Q4 2024	$8.29B R (restated)	$1.65B R (restated)	$1.29B R (restated)	$1.01 R (restated)	—	19.9%	—	10-Q · 24 Feb 2026 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jul 2026	9/1/2026	$1.45	$1.39	+4.3%
Apr 2026	6/3/2026	$1.55	$1.54	+0.7%
Jan 2026	2/17/2026	$1.36	$1.33	+2.3%
Oct 2025	11/18/2025	$1.36	$1.31	+3.8%

Cash and equivalents: $1.69B
Total assets: $93.31B
Total liabilities: $42.46B
Shareholders' equity: $50.23B
Long-term debt: $22.14B
Debt due within a year: $2.54B

8-K · 19 Oct 2026 · Management change

Medtronic plc reported A director or senior management change or compensation event (opens in a new tab)

Medtronic plc filed an 8-K covering a director or senior management change or compensation event, shareholder voting results, Regulation FD disclosure, supporting financial statements or exhibits.
SCHEDULE 13G/A · 17 Oct 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Medtronic plc.
425 · 14 Oct 2026 · Merger or acquisition Announced

Medtronic plc business combination filing (opens in a new tab)

Medtronic plc filed Form 425 (communications about a business combination).
425 · 13 Oct 2026 · Merger or acquisition Announced

Medtronic plc business combination filing (opens in a new tab)

Medtronic plc filed Form 425 (communications about a business combination).
425 · 10 Oct 2026 · Merger or acquisition Announced

Medtronic plc business combination filing (opens in a new tab)

Medtronic plc filed Form 425 (communications about a business combination).

Insider	Date	Transaction	Shares	Average price	Filing
Marinaro Michael EVP, Pres MedSurg and Americas	15 Oct 2026	Open-market sale (S)	−10,420	$96.00	Form 4 (opens in a new tab)
Martha Geoffrey Director, Chairman and CEO	15 Oct 2026	Open-market sale (S)	−50,000	$95.00	Form 4 (opens in a new tab)
Medtronic plc 10% owner	15 Oct 2026	Other (J)	−252,813,348	—	Form 4 (opens in a new tab)
KIIL HARRY SKIP EVP & President Cardiovascular	16 Sep 2026	Open-market sale (S)	−1,483	$93.65	Form 4 (opens in a new tab)
Blomquist Denise L. Chief Accounting Officer	15 Sep 2026	Gift (G)	−600	—	Form 4 (opens in a new tab)
Marinaro Michael EVP, Pres MedSurg and Americas	20 Aug 2026	Tax withholding (F)	−1,084	$92.30	Form 4 (opens in a new tab)
Blomquist Denise L. Chief Accounting Officer	3 Aug 2026	Grant or award (A)	+2,337	—	Form 4 (opens in a new tab)
Walter Matthew R. SVP, Chief HR Officer	3 Aug 2026	Grant or award (A)	+5,769	—	Form 4 (opens in a new tab)
Blomquist Denise L. Chief Accounting Officer	31 Jul 2026	Tax withholding (F)	−212	$85.39	Form 4 (opens in a new tab)
Walter Matthew R. SVP, Chief HR Officer	31 Jul 2026	Tax withholding (F)	−1,675	$85.39	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	128,961,343	1.486%
Blackrock, Inc.	6/30/2026	114,020,787	0.741%
Vanguard Capital Management Llc	6/30/2026	83,816,735	0.579%
State Street Corp	6/30/2026	63,399,315	2.686%
Vanguard Portfolio Management Llc	6/30/2026	34,059,967	1.822%
Geode Capital Management, Llc	6/30/2026	30,192,015	5.066%
Jpmorgan Chase & Co	6/30/2026	27,784,471	-45.492%
Bank Of America Corp /De/	6/30/2026	21,322,401	-18.038%
Massachusetts Financial Services Co /Ma/	6/30/2026	19,872,600	-7.3%
Morgan Stanley	6/30/2026	19,444,871	-6.141%

Previous close: 94.63 USD
Day range: 92.71 – 95.30 USD
52-week range: 73.31 – 106.33 USD
Volume: 10,449,505
Market cap: $119.00B
Average volume: 5,004,808
EPS (FY 2025, diluted): 3.73 USD
Dividends (last 12 months): 2.86 USD
Dividend yield: 3.01%
Ex-dividend date: 25 Sep 2026
Shares outstanding: 1.28B
Beta (5Y monthly): 0.57

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:06 UTC· 1 hour ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:06 UTC· 1 hour ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for MDT yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.